Fineotex Chemical files FY26 BRSR report with zero safety incidents

1 min read     Updated on 18 Aug 2026, 05:52 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Fineotex Chemical Limited filed its FY26 BRSR report, highlighting zero safety incidents and improved environmental disclosures. The company reported rising energy and water usage alongside initial greenhouse gas emission data. Governance metrics show no regulatory penalties or human rights complaints.

powered bylight_fuzz_icon
48601339

*this image is generated using AI for illustrative purposes only.

Fineotex Chemical submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ending March 31, 2026, on August 18, 2026, in compliance with Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The speciality chemicals manufacturer reported a clean safety record for the fiscal year, with zero lost-time injury frequency rates and no fatalities among employees or workers. The company maintains an Occupational Health and Safety Management System aligned with ISO 45001 standards.

Operational Metrics

Fineotex operates six plants and one office nationally, with one international office. Its products serve customers in 14 Indian states and 70 countries. Exports contributed 15.30% to the total turnover for the period.

The company employs 120 permanent staff and 180 workers. Female representation stands at 25.83% among permanent employees and 8.89% among workers. The Board of Directors includes two women, accounting for 28.57% of the total board composition.

Environmental Performance

Total energy consumption rose to 1,827.41 GJ in FY26 from 1,793.52 GJ in the prior year. Renewable energy sources accounted for 340.98 GJ of this total. Water withdrawal increased to 50,080 kilolitres, up from 42,502 kilolitres previously.

Greenhouse gas emissions were disclosed for the first time in this reporting cycle. Scope 1 emissions totaled 162.36 metric tonnes of CO2 equivalent, while Scope 2 emissions reached 330.32 metric tonnes. The combined emission intensity was 1.24 MT per crore of turnover.

Environmental Metric FY26 FY25
Total Energy Consumption (GJ) 1,827.41 1,793.52
Water Withdrawal (KL) 50,080 42,502
Scope 1 + 2 GHG Emissions (MT) 492.68 Nil

Governance and Ethics

The company reported no fines, penalties, or regulatory actions during the year. Zero complaints were received regarding conflict of interest, sexual harassment, or discrimination. All permanent employees and workers received training on human rights and health and safety measures.

Capital expenditure directed toward environmental and social impact improvements accounted for 3.17% of total capex in FY26, compared to nil in the previous year. This includes investments in air emission reduction, water conservation, and solar panel operations.

Historical Stock Returns for Fineotex Chemical

1 Day5 Days1 Month6 Months1 Year5 Years
+0.92%+3.06%+13.06%+78.16%+79.62%+323.69%

How does Fineotex's 1.24 MT per crore emission intensity compare to industry benchmarks for specialty chemical manufacturers, and what specific targets has the company set to reduce this figure in FY27?

Given the 18% increase in water withdrawal, what specific technological upgrades or conservation strategies are driving the 3.17% capex allocation toward water sustainability?

With exports contributing only 15.30% of turnover, how might evolving global ESG regulations impact Fineotex's ability to expand its footprint in the 70 countries it currently serves?

Fineotex Chemical FY26 annual report: consolidated revenue up 44.79%

5 min read     Updated on 18 Aug 2026, 05:51 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Fineotex Chemical Limited released its FY26 annual report disclosing consolidated revenue from operations of ₹77,222.56 lakhs, up 44.79% YoY, and consolidated PAT of ₹12,501.51 lakhs, up 14.50% YoY, driven by the consolidation of CrudeChem Technologies and the commissioning of the Ambernath facility. On a standalone basis, PAT stood at ₹9,188.96 lakhs and revenue at ₹39,687.83 lakhs. The Board recommended a final dividend of ₹0.05 per share and is seeking shareholder approval at the 23rd AGM on September 11, 2026 to raise up to ₹800 crore via equity issuance and to approve related party transactions of up to ₹500 crore between its foreign subsidiaries.

powered bylight_fuzz_icon
48521260

*this image is generated using AI for illustrative purposes only.

Fineotex Chemical Limited has released its Annual Report for FY26, disclosing audited standalone and consolidated financial statements for the year ended March 31, 2026. The report, filed pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, was submitted on August 18, 2026, and is available on the company's website at https://fineotex.com/investor-relation/ . The 23rd Annual General Meeting is scheduled for September 11, 2026 at 4:00 pm (IST) via Video Conferencing/Other Audio-Visual Means.

Financial Performance

On a consolidated basis, Fineotex Chemical reported income from operations of ₹77,222.56 lakhs in FY26, compared to ₹53,333.28 lakhs in FY25, reflecting growth of 44.79%. Consolidated profit after tax (PAT) rose 14.50% to ₹12,501.51 lakhs from ₹10,920.82 lakhs. EBITDA on a consolidated basis amounted to ₹16,781.93 lakhs. Consolidated profit before tax increased to ₹15,303.27 lakhs from ₹14,124.32 lakhs.

On a standalone basis, revenue from operations stood at ₹39,687.83 lakhs, while PAT was ₹9,188.96 lakhs. The standalone topline remained broadly stagnant compared to the prior year.

The following table summarises the key financial highlights (₹ in lakhs):

Metric: FY26 Standalone FY25 Standalone FY26 Consolidated FY25 Consolidated
Total Income: 43,796.71 46,670.72 80,529.56 55,763.95
Profit Before Tax: 11,344.99 12,541.53 15,303.27 14,124.32
Profit After Tax: 9,188.96 9,722.67 12,501.51 10,920.82
EPS (₹, FV ₹1): 0.80 0.86 1.09 0.96

Consolidated revenue by entity

The following table presents entity-wise income from operations (₹ in lakhs):

Entity: FY26 FY25
Fineotex Chemical Limited: 39,687.83 43,922.21
FSPL Specialities Private Limited: 6,638.88 4,139.47
Finoclean Specialities Private Limited: 7.35 9.96
Fineotex Malaysia Limited: 9,837.68 6,596.97
Fineotex Biotex HealthGuard FZE: 23,986.10 99.10
Elimination and adjustments: (2,935.28) (1,434.41)
Total Group Turnover: 77,222.56 53,333.28

Operational Highlights

A significant milestone during FY26 was the commencement of operations at the company's new manufacturing facility at Ambernath. The first phase increased production capacity by 15,000 metric tonnes per annum. On a consolidated basis, production volume stood at 81,731 MT compared with 60,692.40 MT in the prior year, while sales volume increased to 80,356.72 MT from 60,194.47 MT.

In December 2025, Fineotex Biotex Healthguard FZE, a wholly owned foreign subsidiary, acquired a 53.33% equity stake in CrudeChem Technology LLC (CCT Group), a US-based specialty oilfield chemical manufacturer. This acquisition marked the company's strategic entry into the oilfield specialty chemicals segment.

Particulars: FY26 FY25
Production (MT): 81,731 60,692.40
Sales (MT): 80,356.73 60,194.47
Income from Operations (₹ lakhs): 77,222.56 53,333.28

Dividend and Capital Actions

The Board recommended a final dividend of ₹0.05 per equity share of face value ₹1 each for FY26, with a total payout of ₹582.25 lakhs. An interim dividend of ₹0.80 per equity share was declared earlier in September 2025. The record date for the final dividend is September 4, 2026, and payment is to be made on or before September 30, 2026, subject to shareholder approval at the AGM.

During FY26, the company undertook a stock split (1 equity share of ₹2 subdivided into 2 shares of ₹1 each, effective October 31, 2025) and issued 91,66,00,720 bonus equity shares in a 4:1 ratio. As a result, the paid-up share capital as at March 31, 2026 stood at ₹116.45 crore comprising 116,45,00,900 equity shares of face value ₹1 each.

AGM Agenda and Key Proposals

The 23rd AGM on September 11, 2026 will consider the following special business items:

  • Capital raising: Shareholder approval is sought to raise up to ₹800 crore through issuance of equity shares or other eligible securities via private placement, preferential issue, QIP, further public offer, or a combination thereof. Proceeds are intended for capital expenditure, working capital, general corporate purposes, and inorganic growth.
  • Related party transactions: Approval for material related party transactions between Fineotex Biotex HealthGuard FZE (wholly owned foreign subsidiary) and CrudeChem Technology LLC (step-down subsidiary) for FY26-27, capped at an aggregate value of ₹500 crore, comprising sale/purchase/supply of goods or services (up to ₹100 crore) and loans and advances (up to ₹400 crore).
  • Cost auditor remuneration: Ratification of remuneration of ₹50,000 per annum plus applicable taxes and expenses payable to M/s V. J. Talati & Co. as cost auditor for FY26-27.
  • Director re-appointment: Re-appointment of Mrs. Aarti Mitesh Jhunjhunwala (DIN: 07759722) as director, retiring by rotation.

Key AGM and Corporate Action Dates

Event: Date Detail
Record Date / Cut-off Date: September 4, 2026 Dividend eligibility and e-voting
Remote E-voting Period: September 8–10, 2026 9:00 am to 5:00 pm
23rd AGM: September 11, 2026 4:00 pm (IST) via VC/OAVM
Dividend Payment: On or before September 30, 2026 Subject to AGM approval

Credit Rating and Awards

ICRA reaffirmed the company's long-term credit rating at ICRA A+ (Positive) and short-term rating at ICRA A1+. The company was also honoured with the Business Excellence Award 2025 in the Chemicals (SME) category by Dun & Bradstreet and was certified as a "Great Place to Work" for the fourth consecutive time.

Financial Ratios (Standalone)

Ratio: FY26 FY25
Current Ratio: 4.58 3.40
Inventory Turnover Ratio: 6.61 9.66
Debtors Turnover Ratio: 4.00 4.27
Return on Net Worth: 13.28% 19.69%
Net Profit Ratio: 23.15% 22.14%
Return on Capital Employed: 14.98% 19.84%
Debt Equity Ratio: 0 0

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE045J01034/35a14f7d-cdaf-4fd1-8166-07bb4831540a.pdf

Historical Stock Returns for Fineotex Chemical

1 Day5 Days1 Month6 Months1 Year5 Years
+0.92%+3.06%+13.06%+78.16%+79.62%+323.69%

How will the proposed ₹800 crore capital raise impact existing shareholders' equity dilution and future earnings per share growth?

What is the strategic roadmap for integrating CrudeChem Technology LLC to realize synergies in the oilfield specialty chemicals segment?

Will the new Ambernath manufacturing facility's Phase 1 capacity expansion be sufficient to meet projected demand, or are further phases planned?

More News on Fineotex Chemical

1 Year Returns:+79.62%